Podcasts about cancer surgery

Dr Bill Nelson talks to thoracic surgeon, Dr Stephen Yang, about the developments in lung cancer surgery that have resulted in more minimally invasive procedures and improved patient outcomes.

Most medical breakthroughs aren't just about technology, they're about understanding what factors truly drive change. Dr. Marko Simunovic, a surgical oncologist and health systems researcher, shares how he leverages big datasets, collaborative practices, and a willingness to question tradition to improve patient outcomes and transform surgical care. Imagine a world where surgeons routinely consult in groups, where the way wedeliver care is standardized, transparent, and constantly improved through real collaboration. Dr. Simunovic reveals the groundbreaking potential of team-based surgery, collective decision-making, and a shift toward process-driven qualityimprovement. He discusses how surgical culture, combined with systemic barriers like funding and institutional inertia, shapes the pace of adopting new evidence, and how the future may lie in breaking down these barriers with shared knowledge and innovative tech like AI.You'll discover: how large administrative datasets can identify upstream factors contributing to adverse outcomes; why rapid adoption of proven practices depends on compelling evidence; and how surgeons working together more openly can prevent unnecessary harm and improve efficiency. Plus, insights into how mentorship, societal values, and organizational culture influence the pace of change in medicine. Getting urgentcare right isn't just a matter of new devices or drugs, it's aboutunderstanding complex systems, collaboration, and challenging the status quo. Dr. Marko Simunovic, a leader in health services research at McMaster University, combines his background in surgery with a passion for systemic change. His pioneering work aims to unlock the full potential of collaborative, data-informed clinical practice. Tune in to learn how embracing more team-based, process-oriented approaches can revolutionize the future of surgery, and why asking the right questions might be the most powerful tool in healthcare innovation.

This mini-series on Behind the Knife delves into the technical aspects of the Operative Standards for Cancer Surgery, developed through the American College of Surgeons Cancer Research Program and Cancer Surgery Standards Program. This episode highlights sentinel lymph node biopsy for breast cancer.Hosts:- Lexy (Alexandra) Adams, MD, MPH (@lexyadams16) is a Surgical Oncology fellow at MD Anderson Cancer Center.- Lauren Postlewait, MD, FACS, is an Associate Professor of Surgery at Emory University School of Medicine and is the Medical Director of the Breast Center at Grady Memorial Hospital in Atlanta, GA.- Chantal Reyna, MD, FACS (@kprgrl3) is a Breast surgical oncologist at Loyola University Medical Center in Chicago, IL and serves as the oncology clinical lead for the breast service line.Guest:- Susan E. Pories, MD, FACS (@SusanPoriesMD) is a professor of surgery, vice chair for quality and safety, and director of the Rutger's Breast Center at the University hospital. Learning Objectives: -       Understand the definition and identification of axillary sentinel lymph node. -       Understand the technique for injecting tracer or dye to perform sentinel lymph node biopsy. -       Understand the importance of preincision drainage evaluation and transcutaneous localization.-       Understand techniques to minimize seroma formation.Links to Papers Referenced in this EpisodeOperative Standards for Cancer Surgery, Volume 1: Breast, Lung, Pancreas, Colonhttps://www.facs.org/quality-programs/cancer-programs/cancer-surgery-standards-program/operative-standards-for-cancer-surgery/purchase/Kindle edition:https://www.amazon.com/Operative-Standards-Cancer-Surgery-Section-ebook/dp/B07MWSNFSBSentinel-lymph-node resection compared with conventional axillary-lymph-node dissection in clinically node-negative patients with breast cancer: overall survival findings from the NSABP B-32 randomised phase 3 trial Lancet Oncol. 2010 Oct;11(10):927-33.https://pubmed.ncbi.nlm.nih.gov/20863759/Improved Axillary Evaluation Following Neoadjuvant Therapy for Patients With Node-Positive Breast Cancer Using Selective Evaluation of Clipped Nodes: Implementation of Targeted Axillary Dissection J Clin Oncol. 2016 Apr 1;34(10):1072-8.https://pubmed.ncbi.nlm.nih.gov/26811528/The false-negative rate of sentinel node biopsy in patients with breast cancer: a meta-analysis World J Surg. 2012 Sep;36(9):2239-51. https://pubmed.ncbi.nlm.nih.gov/22569745/Effect of lymphoscintigraphy drainage patterns on sentinel lymph node biopsy in patients with breast cancer Am J Surg. 2005 Oct;190(4):557-62.https://pubmed.ncbi.nlm.nih.gov/16164919/Sentinel Lymph Node Biopsy vs No Axillary Surgery in Patients With Small Breast Cancer and Negative Results on Ultrasonography of Axillary Lymph Nodes: The SOUND Randomized Clinical Trial JAMA Oncol. 2023 Nov 1;9(11):1557-1564.https://pubmed.ncbi.nlm.nih.gov/37733364/Choosing Wisely GuidelinesSociety of Surgical Oncology. Released 2016 July 12; last updated 2020 November 13. Choosing Wisely: Five Things Physicians and Patients Should Question.https://surgonc.org/wp-content/uploads/2020/11/SSO-5things-List_2020-Updates-11-2020.pdfPlease visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listenBehind the Knife Premium:General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-reviewOral Board Simulator: https://app.behindtheknife.org/oral-board-simulatorTrauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlasDominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkshipDominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotationVascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-reviewColorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-reviewSurgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-reviewCardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-reviewDownload our App:Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

You've got burning questions, we've got answers! Call or Text us for the worst advice imaginable, and we may feature it on an upcoming podcast! ** 801-513-3373 **Welcome back to the table! We've been gone for a minute, and man, do we have some catching up to do. This episode is a wild ride through a gauntlet of family medical nightmares. We're talking torn biceps and rotator cuffs , a rib cracked in the most pathetic way possible during a warehouse shoulder-check , and a terrifying run-in with the "Widowmaker" heart attack. Plus, Tony recaps his insanely ritzy NYC trip (complete with hotboxed subways ), we dive into the existential dread of watching our parents and kids get older, and we wrap it up with a classic Medusa joke. Are we cursed? Probably. Grab a chair and join the chaos.00:00 - Start!00:13 - The Transgender Vegan Joke01:05 - Missing Chris & Welcome Back02:27 - Kara's Insane Shoulder Surgery09:27 - How Zach Broke His Rib19:29 - Dog Trips, Punctured Lungs, & Face Cancer22:49 - Tony's Ritzy NYC Trip38:34 - NYC Pizza & Hotboxed Subways48:49 - The Great Gatsby Wedding Experience52:12 - Wall Street & The Ghostbusters Firehouse54:11 - The Truth About the Hollywood Walk of Fame56:59 - The Terrifying Widowmaker Heart Attack1:02:40 - The Existential Dread of Aging Parents1:04:22 - Time Flying By & Kids Growing Up Too Fast1:14:46 - Teenagers Getting Driving Permits1:21:59 - Medusa's Dirty Secret & OutroReddit- Our Subreddit: https://www.reddit.com/r/FivesACrowd- Our Account: https://www.reddit.com/user/FivesACrowdPodcastFollow Our Personal AccountsAustin - https://allmylinks.com/austinspomerCam - https://www.instagram.com/effinburch/Chris - https://www.instagram.com/thechrishummel/Tony - https://www.instagram.com/theonlytonyc/Zach - https://www.instagram.com/zvanbeekum/Hashtags#Podcast #MedicalNightmares #Widowmaker #HeartAttackSurvivor #NYCTrip #ComedyPodcast #GettingOlder #NYC #ForTheCrowd #JoinTheCrowd #HitTheBell #PodcastP.O. Box**Please no packages, letters only**Five's A Crowd Podcast1123 N Fairfield Rd #1373 Layton, UT 84041

Nick is joined by Lydia Hislop for Monday's show, looking through the racing headlines from around the world. With the review of Aintree occupying its own edition, this show focuses on the Flat and the Classic trials this week, but opens with the news that veteran rider Joe Fanning, out of the saddle since November, has had surgery for prostate cancer, but is already eyeing a return to race riding. Also on today's show, news from Ballydoyle on running plans for this week, plus David Menuisier on his Nell Gwyn and classic hopeful Inis Mor, trainer Adrian Bott reflecting on the triumph of Sir Delius in the Queen Elizabeth Stakes at Randwick, and Fernando Laffon on the two progeny of Persian King that have lit up the early French Classic Trials.

Nick is joined by Lydia Hislop for Monday's show, looking through the racing headlines from around the world. With the review of Aintree occupying its own edition, this show focuses on the Flat and the Classic trials this week, but opens with the news that veteran rider Joe Fanning, out of the saddle since November, has had surgery for prostate cancer, but is already eyeing a return to race riding. Also on today's show, news from Ballydoyle on running plans for this week, plus David Menuisier on his Nell Gwyn and classic hopeful Inis Mor, trainer Adrian Bott reflecting on the triumph of Sir Delius in the Queen Elizabeth Stakes at Randwick, and Fernando Laffon on the two progeny of Persian King that have lit up the early French Classic Trials.

I've been thinking a lot lately about my surgery back in 2023,  when I was diagnosed with invasive carcinoma in the left breast.  At that time,  I chose to have a left mastectomy.    I'm sharing what I have come to realize recently about that surgery and how I have honed  in on one of the reasons it may have been a disadvantage to be the last surgical case of the day for my breast surgeon.   The recovery process could have been impacted by the approach the breast surgeon used. I was going to surgery at 4PM (although my original surgery time was 2 PM) and my surgeon, I'm quite certain,  was operating all day long before she got to me.     Immediately after the mastectomy, I went through a pretty rigorous recovery process to avoid losing the skin over my implant.    I recently visited a plastic surgeon for consultation about a prophylactic right mastectomy. During this recent consultation,  I learned more about what could have  been the reason there was concern about the adequacy of blood flow and potential wound healing complications at the time I was in the operating room with that left mastectomy.    What I learned added one more reason to my list of points as to why it's important to have your surgery in the morning and not be the very last person of the day.    The content of this podcast is not intended to substitute professional medical advice, diagnosis, or treatment. Always consult a healthcare professional regarding your healthcare questions and concerns. This podcast contains opinions of the host. If you'd like to be the first to receive updates and exclusive content from the upcoming Breast Cancer Life newsletter, please email me at connect@breastcancerlife.org. I'd love to have you on the list!   LET'S CONNECT: connect@breastcancerlife.org  Follow us on Pinterest 

In this episode of the PRS Global Open Keynotes Podcast, A/Prof Nicola Dean and Dr. Sam Hanshin discuss the psychosocial impact of the surgical treatment of facial skin cancers. Patient satisfaction, cancer concern and changes in sun safe behavior were tracked using the FACE-Q Patient Reported Outcome Measure. This episode discusses the following PRS Global Open article: "Eco-audit of the Nail Bed Injury Treatment Pathway at a Tertiary Care Hospital" by Samuel G. Handshin, Mary I. Iengo, Tamara A. Crittenden, Phillipa van Essen, Andrea Smallman and Nicola R. Dean. Read it for free on PRSGlobalOpen.com: https://journals.lww.com/prsgo/fulltext/2026/02000/measuring_outcomes_of_facial_skin_cancer_surgery.45.aspx A/Prof Nicola Dean is the head of the department of plastic and reconstructive surgery at the Flinders Medical Center and affiliated with the Flinders University College of Medicine and Public Health. Dr. Sam Hanshin is a plastic surgery resident in Adelaide. Your host, Dr. Damian Marucci, is a board-certified plastic surgeon and Associate Professor of Plastic Surgery at the University of Sydney in Australia. #PRSGlobalOpen; #KeynotesPodcast; #PlasticSurgery; Plastic and Reconstructive Surgery- Global Open The views expressed by hosts and guests are their own and do not necessarily reflect the official policies or positions of ASPS.

This episode I share what I learned recently that would've helped me more when I was diagnosed with breast cancer in 2023 and seeking the guidance of plastic surgeon and the breast surgeon. My care ultimately was good enough But I realize that getting a second opinion, and looking at more than one surgeon for each part of the surgery would've benefited as really work to make an informed decision On which doctors would be best for each part of my initial cancer care.  The content of this podcast is not intended to substitute professional medical advice, diagnosis, or treatment. Always consult a healthcare professional regarding your healthcare questions and concerns. This podcast contains opinions of the host. If you'd like to be the first to receive updates and exclusive content from the upcoming Breast Cancer Life newsletter, please email me at connect@breastcancerlife.org. I'd love to have you on the list!   LET'S CONNECT: connect@breastcancerlife.org  Follow us on Pinterest 

The latest trends on colorectal cancer surgery and survival with guest Anne Mongiu MD PhD, FACS, FASCRS Yale Cancer Center visit: www.yalecancercenter.org email: canceranswers@yale.edu call: 203-785-4095

This hypnosis session helps a client mentally and emotionally prepare for surgery, a mastectomy, and cosmetic surgery. Adam helps them to reduce anxiety, feel optimistic, and believe that healing will take place quickly to a speedy recovery after successful surgery. To access a subscriber-only version with no intro, outro, explanation, or ad breaks and 24 hours earlier than everyone else, tap 'Subscribe' nearby or click the following link.⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠https://creators.spotify.com/pod/profile/adam-cox858/subscribe⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠⁠

March is Women's History Month, and today's episode is more than medicine…It's a story of science, courage, and the voices of women who changed everything.For decades, women were told that survival required sacrifice —not just of the breast… but of identity.Radical surgeries.Permanent disability.No questions asked.But something powerful happened.

For patient referrals: call 480-256-6444Can ultrasound liquefy tumors? In this episode of Beyond the Rounds, we explore histotripsy — a novel, non-thermal ultrasound therapy that can destroy tumors without surgery, heat, or radiation. Dr. Nolan Fisher sits down with surgical oncologist Dr. Michael Choti, Chief of Surgery at Banner MD Anderson Cancer Center, to discuss how this emerging technology may change the way liver tumors are treated.Using focused ultrasound energy to create microscopic cavitation bubbles, histotripsy mechanically breaks down tumor tissue while sparing critical structures like blood vessels and bile ducts. The result: precise tumor destruction in locations that may be difficult or impossible to treat with traditional surgery or thermal ablation.This episode explores how histotripsy works, where it fits in today's treatment landscape, and why clinicians should remain both excited and cautious as the technology evolves.This episode is designed for physicians, advanced practice providers, and clinicians who want a practical understanding of emerging technologies in surgical oncology and liver tumor management.What We Cover• What histotripsy is and how cavitation-based ultrasound destroys tumors• Why histotripsy differs from thermal ablation techniques• The “heat sink effect” and why tumors near blood vessels are difficult to treat• How histotripsy may expand treatment options for liver tumors• Using histotripsy as a bridge to liver transplant• The potential immune effects of tumor liquefaction (abscopal effect)• When histotripsy is appropriate — and when it's not• Current FDA approvals and ongoing research• Why careful patient selection and multidisciplinary evaluation matterKey Topics for CliniciansLiver tumorsColorectal liver metastasesHepatocellular carcinoma (HCC)Liver transplant bridging therapyImage-guided tumor ablationHistotripsy technologySurgical oncology innovationMultidisciplinary cancer careAbout Our GuestDr. Michael Choti is Chief of Surgery at Banner MD Anderson Cancer Center and a nationally recognized surgical oncologist specializing in gastrointestinal and hepatobiliary cancers. His career has focused on liver tumors, colorectal cancer metastases, and advancing surgical and minimally invasive treatments for complex cancers. He previously served as Chair of the Department of Surgery at UT Southwestern and trained at Yale, the University of Pennsylvania, and Memorial Sloan Kettering Cancer Center.How to Refer a PatientIf you believe a patient may benefit from evaluation at Banner MD Anderson Cancer Center:Banner Health providers: Use Cerner's Ambulatory Referral Management (ARM) tool.Community providers:Fax referrals to 480-256-4607or call 480-256-6444 to schedule a patient for evaluation.DisclaimerThis podcast is intended for educational purposes only and is designed for a clinical audience. Any patient scenarios discussed are modified and de-identified to protect privacy. No protected health information (PHI) is disclosed. The information presented should not replace independent medical judgment or individualized patient care decisions.Subscribe to Beyond the Rounds for physician-focused conversations on clinical innovation, specialty collaboration, and evolving standards of care.

What if the way you recover from breast cancer surgery actually starts before you ever enter the operating room? In this powerful and practical episode, Jen Delvaux sits down with Dr. Rebecca Knackstedt, MD, PhD—reconstructive surgeon, functional medicine expert, and founder of Clara Recovery—to talk about something every woman facing surgery needs to know about: prehabilitation. Dr. Knackstedt explains how preparing your body ahead of surgery through proper nutrition, movement, stress reduction, and sleep can dramatically improve healing, reduce complications, and speed up recovery. They dive into why so many women feel underprepared going into surgery, the gaps in traditional medical education around nutrition, and how simple, proactive steps can make a huge difference in outcomes. This conversation is empowering, practical, and filled with actionable advice for anyone navigating breast cancer or any major surgery. In This Episode We Cover: What prehabilitation is and why it's crucial for surgical recovery How nutrition directly impacts healing after surgery Why many doctors receive very little nutrition education The powerful role of protein, fiber, and whole foods in recovery How exercise before surgery improves strength and healing speed The connection between stress management and surgical outcomes Simple tools to calm the nervous system before and after surgery Why sleep hygiene is a foundational part of healing How patients can better advocate for themselves in medical settings The mission behind Clara Recovery and tailored surgical supplements Practical steps every woman can take to feel more prepared and empowered ___________________________________________________________________________

Recent randomized controlled trials have shown that routine perioperative palliative care does not improve outcomes for patients undergoing curative-intent cancer surgery. No, that wasn't a typo. Regardless of how the data were analyzed, the findings remained consistent: perioperative palliative care DID NOT improve outcomes in the only two randomized controlled trials conducted in this area—the SCOPE and PERIOP-PC trials. Null trials like these often receive less attention in academic and clinical settings, but they can be profoundly practice-changing. Consider the Shannon Carson study on palliative care for chronically critically ill patients. While some have argued it "wasn't a palliative care study," I've always regarded it as one of the most significant studies for understanding not what works—but what doesn't—for palliative care in specific patient populations. The same holds true for the SCOPE and PERIOP-PC trials. Both were null, but their findings are deeply relevant to clinical practice. That's why we invited the lead authors, Rebecca Aslakson (PERIOP-PC) and Myrick "Ricky" Shinall (SCOPE), to share insights into what they did in their studies and why they think they got the results that they did. One key takeaway for me from this discussion was the idea that patients undergoing curative-intent surgery might simply be too early in their cancer trajectory to derive meaningful benefits from palliative care, and maybe the focus should be more on geriatrics. I especially appreciated the closing discussion about the future of research in this area: if routine perioperative palliative care doesn't improve outcomes, what should the next generation of studies focus on? Eric Widera   Studies we talk about during the podcast Aslakson et al. Effect of Perioperative Palliative Care on Health-Related Quality of Life Among Patients Undergoing Surgery for Cancer: A Randomized Clinical Trial. JAMA Netw Open. 2023 Shinall et al. Effects of Specialist Palliative Care for Patients Undergoing Major Abdominal Surgery for Cancer: A Randomized Clinical Trial. JAMA Surg. 2023 Carson et al. Effect of Palliative Care–Led Meetings for Families of Patients With Chronic Critical Illness: A Randomized Clinical Trial. JAMA. 2016 Holdsworth et al. Patient Experiences of Specialty Palliative Care in the Perioperative Period for Cancer Surgery. JPSM. 2024 Williams et al. Patient Perceptions of Specialist Palliative Care Intervention in Surgical Oncology Care. Am J Hosp Palliat Care. 2025  Yefimova et al. Palliative Care and End-of-Life Outcomes Following High-risk Surgery. JAMA Surg. 2020   

This new mini-series on Behind the Knife will delve into the technical aspects of the Operative Standards for Cancer Surgery, developed through the American College of Surgeons Cancer Research Program. This second episode highlights the thyroid cancer operative standard.Hosts:Tracy Wang, MD, MPH, FACS is a Professor of Surgery and Vice-Chair of Strategic and Professional Development at the Medical College of Wisconsin with a clinical focus on endocrine surgical oncology. Vladmir Neychev, MD, PhD is a Professor of Surgery at the University of Central Florida College of Medicine with a clinical focus on endocrine surgical oncology.Jack Sample, MD (@JackWSample) is a General Surgery Resident at Mayo Clinic Rochester.Guests:Elizabeth Grubbs, MD (@EGrubbsMD) is a Professor of Surgical Oncology at MD Anderson where she specializes in endocrine tumors, with expertise in cancer of the thyroid.David Hughes, MD is a Clinical Associate Professor of Surgery at University of Michigan, where he focuses on surgical diseases of the endocrine system, including a particular focus on the diagnosis and management of papillary thyroid cancer.Learning Objectives: Understand key preoperative and intraoperative aspects of the evaluation and treatment of patients with biopsy-proven papillary thyroid carcinoma (PTC) greater than or equal to 1 cm. Define factors that guide decision making regarding the extent of surgical resection (lobectomy versus total thyroidectomy) for PTC.Links to Papers Referenced in this EpisodeOperative Standards for Cancer Surgery, Volume 2: Thyroid, Gastric, Rectum, Esophagus, Melanomahttps://www.facs.org/quality-programs/cancer-programs/cancer-surgery-standards-program/operative-standards-for-cancer-surgery/purchase/Kindle edition:Amazon.com: Operative Standards for Cancer Surgery: Volume 2, Section 1: Thyroid eBook : Program, American College of Surgeons Clinical Research, Katz, Matthew HG: Kindle StoreImpact of Extent of Surgery on Survival for Papillary Thyroid Cancer Patients Younger Than 45 years. https://pubmed.ncbi.nlm.nih.gov/25337927/ Extent of Surgery Affects Survival for Papillary Thyroid Cancer. https://pubmed.ncbi.nlm.nih.gov/17717441/Sponsor Disclaimer: Visit goremedical.com/btkpod to learn more about GORE® SYNECOR Biomaterial, including supporting references and disclaimers for the presented content.  Refer to Instructions for Use at eifu.goremedical.com for a complete description of all applicable indications, warnings, precautions and contraindications for the markets where this product is available. Rx only Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.  If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listenBehind the Knife Premium:General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-reviewTrauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlasDominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkshipDominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotationVascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-reviewColorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-reviewSurgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-reviewCardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-reviewDownload our App:Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

In this episode of SurgOnc Today, Casey Allen leads a discussion with Oluwadamilola Fayanju, Laura Dominici, Michael Egger, Cristina O'Donoghue, and Winta Mehtsun, exploring how value-based care principles intersect with access, equity, and health policy in surgical oncology. The conversation highlights social determinants of health, rural outreach, and global initiatives advancing high-quality, value-based cancer surgery.

Moderator: James P. Rathmell, M.D. Participants: Elliott Bennett-Guerrero, M.D. and Juan P. Cata, M.D. Articles Discussed: Anesthesia Type During Cancer Surgery: Results of the GA-CARES Randomized, Multicenter Trial Volatile General Anesthetics and Oncologic Surgery: A Safe Choice

In this episode, Gregory J. Tiesi, MD, FACS, FSSO, hosted a discussion about innovations in regional cancer therapies. Dr Tiesi is the medical director of Hepatobiliary Surgery at the Hackensack Meridian Jersey Shore University Medical Center in Toms River and Brick, New Jersey. He was joined by: Anthony Scholer, MD, FACS, FSSO, a surgical oncologist specializing in hepatobiliary surgery, at Hackensack Meridian Medical Group and Jersey Shore University Medical Center in Neptune, New Jersey Benjamin Jon Golas, MD, FACS, regional chief of Surgical Oncology for Hackensack Meridian Health's Central Region, surgical director of Oncology Services at Jersey Shore University Medical Center, vice chair of Surgery at Jersey Shore University Medical Center Cancer Surgery, and an associate professor of surgery at the Hackensack Meridian School of Medicine in Neptune and Edison, New Jersey Eric Pletcher, MD, a surgeon specializing in Complex General Surgical Oncology at Hackensack Meridian JFK University Medical Center in Edison Drs Tiesi, Scholer, Golas, and Pletcher chatted about the use of pressurized intraperitoneal aerosolized chemotherapy (PIPAC), a minimally invasive regional cancer therapy designed for patients with peritoneal metastases or primary peritoneal cancers. The experts explained that this laparoscopic approach overcomes several limitations of traditional systemic treatments by delivering aerosolized chemotherapy in fine droplets under high pressure into the peritoneal cavity. This process ensures uniform drug distribution and enhanced tissue penetration, allowing for efficacy with lower systemic drug concentrations, they noted.  PIPAC candidates typically present with unresectable or recurrent disease, or symptomatic malignant ascites, and should have an ECOG performance status between 0 and 2, they elaborated. The procedure, which is repeatable every 4 to 6 weeks, includes diagnostic laparoscopy, quantification of the peritoneal carcinomatosis index, and serial biopsies to assess treatment response. They emphasized that PIPAC has a favorable safety profile, with low 30-day mortality rates and minimal grade 3/4 adverse effects reported in clinical trials. Additionally, they stated that clinical data indicate high pathologic response rates and the potential for disease downstaging, enabling some patients who were initially deemed unresectable to become eligible for subsequent cytoreductive surgery and hyperthermic intraperitoneal chemotherapy. Of note, the experts reported that PIPAC is designed to be integrated seamlessly with concurrent systemic therapy.

Evolution of Cancer Surgery: How Far Have We Come? with guest Dr. Kevin Billingsley November 30, 2025 Yale Cancer Center visit: http://www.yalecancercenter.org email: canceranswers@yale.edu call: 203-785-4095

Evolution of Cancer Surgery: How Far Have We Come? with guest Dr. Kevin Billingsley November 30, 2025 Yale Cancer Center visit: http://www.yalecancercenter.org email: canceranswers@yale.edu call: 203-785-4095

Pippa Hudson speaks to physiotherapist Cheryl Gaynor about the risk of a condition called cording which may develop after breast cancer surgery. Lunch with Pippa Hudson is CapeTalk’s mid-afternoon show. This 2-hour respite from hard news encourages the audience to take the time to explore, taste, read, and reflect. The show - presented by former journalist, baker and water sports enthusiast Pippa Hudson - is unashamedly lifestyle driven. Popular features include a daily profile interview #OnTheCouch at 1:10 pm. Consumer issues are in the spotlight every Wednesday while the team also unpacks all things related to health, wealth & the environment. Thank you for listening to a podcast from Lunch with Pippa Hudson Listen live on Primedia+ weekdays between 13:00 and 15:00 (SA Time) to Lunch with Pippa Hudson broadcast on CapeTalk https://buff.ly/NnFM3Nk For more from the show, go to https://buff.ly/MdSlWEs or find all the catch-up podcasts here https://buff.ly/fDJWe69 Subscribe to the CapeTalk Daily and Weekly Newsletters https://buff.ly/sbvVZD5 Follow us on social media: CapeTalk on Facebook: https://www.facebook.com/CapeTalk CapeTalk on TikTok: https://www.tiktok.com/@capetalk CapeTalk on Instagram: https://www.instagram.com/ CapeTalk on X: https://x.com/CapeTalk CapeTalk on YouTube: https://www.youtube.com/@CapeTalk567 See omnystudio.com/listener for privacy information.

This new mini-series on Behind the Knife will delve into the technical aspects of the Operative Standards for Cancer Surgery, developed through the American College of Surgeons Cancer Research Program. This first episode highlights the colon cancer operative standard. Hosts: Timothy Vreeland, MD, FACS (@vreelant) is an Assistant Professor of Surgery at the Uniformed Services University of the Health Sciences and Surgical Oncologist at Brooke Army Medical Center Lexy (Alexandra) Adams, MD, MPH (@lexyadams16) is a Surgical Oncology fellow at MD Anderson Cancer Center. Guest: George Chang, MD, MS, MHCM, FACS, FASCRS, FSSO is a Professor and the interim Department Chair in the Department of Colon and Rectal Surgery at MD Anderson Cancer Center.   Learning Objectives: The extent of colon mobilization and resection depends on tumor location, with high vascular ligation of the tumor-bearing segment to complete adequate regional lymphadenectomy. The technical steps of right colectomy are reviewed, including high ligation of the ileocolic pedicle at the level of the superior mesenteric vein, and the right branch of the middle colic artery if present. Tips and tricks are discussed to identify vascular structures and avoid central vascular injury. Links to Papers Referenced in this Episode Operative Standards for Cancer Surgery, Volume 1: Breast, Lung, Pancreas, Colon https://www.facs.org/quality-programs/cancer-programs/cancer-surgery-standards-program/operative-standards-for-cancer-surgery/purchase/ Kindle edition: https://www.amazon.com/Operative-Standards-Cancer-Surgery-Section-ebook/dp/B07MWSNFSB Short-term outcomes of complete mesocolic excision versus D2 dissection in patients undergoing laparoscopic colectomy for right colon cancer (RELARC): a randomized, controlled, phase 3, superiority trial Lancet Oncol. 2021 Mar; 22(3):391-401. https://pubmed.ncbi.nlm.nih.gov/33587893/ Impact of Proximal Vascular Ligation on Survival of Patients with Colon Cancer. Ann Surg Oncol. 2018 Jan;25(1):38-45. https://pubmed.ncbi.nlm.nih.gov/27942902/ Please visit https://behindtheknife.org to access other high-yield surgical education podcasts, videos and more.   If you liked this episode, check out our recent episodes here: https://behindtheknife.org/listen Behind the Knife Premium: General Surgery Oral Board Review Course: https://behindtheknife.org/premium/general-surgery-oral-board-review Trauma Surgery Video Atlas: https://behindtheknife.org/premium/trauma-surgery-video-atlas Dominate Surgery: A High-Yield Guide to Your Surgery Clerkship: https://behindtheknife.org/premium/dominate-surgery-a-high-yield-guide-to-your-surgery-clerkship Dominate Surgery for APPs: A High-Yield Guide to Your Surgery Rotation: https://behindtheknife.org/premium/dominate-surgery-for-apps-a-high-yield-guide-to-your-surgery-rotation Vascular Surgery Oral Board Review Course: https://behindtheknife.org/premium/vascular-surgery-oral-board-audio-review Colorectal Surgery Oral Board Review Course: https://behindtheknife.org/premium/colorectal-surgery-oral-board-audio-review Surgical Oncology Oral Board Review Course: https://behindtheknife.org/premium/surgical-oncology-oral-board-audio-review Cardiothoracic Oral Board Review Course: https://behindtheknife.org/premium/cardiothoracic-surgery-oral-board-audio-review Download our App: Apple App Store: https://apps.apple.com/us/app/behind-the-knife/id1672420049 Android/Google Play: https://play.google.com/store/apps/details?id=com.btk.app&hl=en_US

New options for knee pain—radiation and embolization; Popeye was right to power-up with spinach; Conquering inflammation; Methane-predominant SIBO; Unnecessary back surgery on seniors is rampant; Medicare Advantage patients often relegated to inferior cancer surgery. 

BUFFALO, NY – October 20, 2025 – A new #research paper was #published in Volume 16 of Oncotarget on October 16, 2025, titled “Widespread folate receptor expression in pediatric and adolescent solid tumors – opportunity for intraoperative visualization with the novel fluorescent agent pafolacianine.” In this study, led by first author Ashley C. Dodd from Ann & Robert H. Lurie Children's Hospital and corresponding author Timothy B. Lautz from the same institution and Northwestern University Feinberg School of Medicine, researchers discovered that folate receptor beta (FRβ) is widely expressed in various pediatric and adolescent solid tumors. This finding highlights FRβ as a promising target for improving the accuracy of tumor surgery using a fluorescent imaging agent known as pafolacianine. Pediatric cancers are often challenging to remove completely during surgery, particularly when tumors spread or form small metastases. Fluorescence-guided surgery is a method that helps surgeons better identify tumors during operations using special imaging dyes. However, commonly used dyes such as indocyanine green are not tumor-specific and rely on general features of blood vessel permeability, limiting their precision. In this study, researchers investigated the potential of pafolacianine, a next-generation dye that targets folate receptors, for pediatric use. Folate receptors are proteins commonly found on the surface of cancer cells. Pafolacianine is already FDA-approved for adults with ovarian and lung cancers due to its ability to bind these receptors and highlight tumors during surgery. The research team analyzed tissue samples from 13 young patients diagnosed with various cancers, including Wilms tumor, osteosarcoma, synovial sarcoma, rhabdomyosarcoma, Ewing sarcoma, and neuroblastoma. The results showed that FRα was predominantly absent, whereas FRβ was present in 100% of the tumor samples. Notably, FRβ appeared both on the tumor cells and in the surrounding tumor microenvironment but showed little to no expression in normal tissue, making it an excellent candidate for targeted imaging. “In this study, we performed immunohistochemistry staining on slides obtained from a range of pediatric patients with solid tumors.” This consistent expression of FRβ in pediatric tumors is a significant and novel finding. Earlier studies primarily linked FRβ to immune cells called tumor-associated macrophages. This study reveals that FRβ is also expressed directly on tumor tissue, which could help surgeons better distinguish cancer from healthy tissue during procedures. Based on these results, the team has launched a clinical trial to evaluate pafolacianine in children undergoing surgery for metastatic lung tumors. If successful, this method could make pediatric cancer surgery safer and more effective. Overall, this study suggests that targeting FRβ with pafolacianine could serve as a tumor-agnostic imaging strategy, applicable across a wide range of pediatric solid tumors. This represents a potential advancement in real-time surgical imaging and a step forward in pediatric cancer care. DOI - https://doi.org/10.18632/oncotarget.28772 Correspondence to - Timothy B. Lautz - TLautz@luriechildrens.org Abstract video - https://www.youtube.com/watch?v=0its0QkOcwM Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/ To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: Facebook - https://www.facebook.com/Oncotarget/ X - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh MEDIA@IMPACTJOURNALS.COM

HOST: Hildy Grossman, CO-HOST: Jordan Rich GUEST: Chi Fu Jeffrey Yang. MD, Thoracic surgeon at Massachusetts General Hospital, Professor of surgery at Harvard Medical School For any cancer patient facing surgery, there are always questions and worries. Hildy interviews an outstanding thoracic surgeon at Massachusetts General Hospital, Chi Fu Jeffrey yang, MD. They discuss the … Continue reading CUT IT OUT! What To Know About Lung Cancer Surgery →

Love the episode? Send us a text!In this episode of Breast Cancer Conversations, host Laura Carfang sits down with Dr. Evan Garfein, Chief of Plastic Surgery at Montefiore Medical Center, Professor of Surgery at Albert Einstein College of Medicine, and Co-Founder of Greenwich Street Aesthetics. With more than 60 peer-reviewed publications, three biomedical patents, and a leadership role in shaping New York State's groundbreaking breast reconstruction equity law, Dr. Garfein brings unmatched insight into the intersection of medicine, policy, and patient empowerment.Together, Laura and Dr. Garfein unpack:How breast reconstruction has evolved—and where the field is headedWhat patients need to know about their rights, options, and insurance coverageThe real-world impact of legislation that expands access and equity in reconstructive careThe latest innovations in surgical techniques and materials that are reshaping outcomesThe emotional and psychological dimensions of reconstruction and recoveryWhether you're a patient, caregiver, or clinician, this conversation offers valuable guidance on making informed decisions and navigating the post-mastectomy journey with confidence.Attend a free virtual SurvivingBreastCancer.org program (support groups, yoga, medication, expressive writing, art expression, and more!):https://www.survivingbreastcancer.org/eventsSubscribe to our weekly newsletterhttps://www.survivingbreastcancer.org/subscribeFollow us on InstagramSurvivingBreastCancer.org: https://www.survivingbreastcancer.org/Breast Cancer Conversations: https://www.instagram.com/breastcancerconversations/Support our Podcast, every dollar counts!https://givebutter.com/0fCiEUSupport the showLatest News: Join our Tell Cancer To Go #TakeAHike October 25, 2025 fundraiser! It's free to sign up! Learn more and start your team! Become a Breast Cancer Conversations+ Member! Sign Up Now.

In this episode of the "Southern Medicine Podcast," J. Quincy Brown, PhD, and Randy Glick, BSB/PM, MCP discuss the state of the art in next-generation surgical pathology imaging methods for fresh-tissue histology, as well as the need and requirements for intraoperative tumor margin imaging systems. Another topic detailed is the integration of imaging hardware and AI for clinical decision making. Dr. J. Quincy Brown is a Professor of Biomedical Engineering at Tulane University and is a biomedical engineer whose career has been focused on the development and translation of light-based sensing and imaging technologies in medicine. Recently, he and his team were selected as an awardee of the Advanced Research Projects Agency for Health (ARPA-H) Precision Surgical Interventions program. The project, called MAGIC-SCAN, is seeking to develop an end-to-end, human + AI collaborative rapid microscopic scanner for comprehensive pathologic imaging of resected tumors in the operating room. 

What if artificial intelligence could help save your erections during prostate cancer surgery?In this groundbreaking episode of the Dr. Geo Prostate Podcast, Dr. Geo sits down with world-renowned urologist and sexual health pioneer Dr. Arthur "Bud" Burnett from Johns Hopkins. Together, they discuss an exciting new frontier in men's health: using AI and intraoperative neuromonitoring to preserve erectile function during prostate cancer surgery.Dr. Burnett shares his four decades of experience and explains how advanced techniques — including real-time nerve mapping and AI-guided signals during surgery — are transforming outcomes for men. Imagine a future where surgeons can “see” and protect the exact nerves critical for erections, like having a GPS guiding them in real time.They also dive into:✅ The evolution of erectile dysfunction treatments — from Yohimbine to Viagra and beyond✅ The history and future of penile implants, including the possibility of app-controlled devices✅ Why nerve-sparing techniques alone may not be enough to preserve function after prostatectomy✅ How AI and precision medicine are changing surgical outcomes and offering men more hopePlus, Dr. Burnett discusses upcoming clinical trials and how men can potentially participate today at Johns Hopkins.

There are new realizations all the time in this breast cancer life experience. I recently realized I need to preserve the veins in my arm not affected by breast cancer surgery. I have been mindful about not getting any injections, blood draws or bug bites on my left arm since I had my mastectomy and sentinel lymph node dissection 2 years ago. Recently I realized that preserving the veins in my right arm is something to be mindful about.  I have had a few blood draws over the past year. These are generally drawn from the same place in my right arm, at the bend of the elbow. The phlebotomists are always good at hitting the vein on the first attempt, which I appreciate greatly. However, I recently thought about the effect of consistently having blood drawn in the same place. There could be scarring there. I realize it is possible that in the future, I could need IVs or other labs that are done at the same place. I need to preserve the veins on my unaffected side.  If it were not for breast cancer, this would not be an issue. This is another reason I make this podcast - to share the experience of all that encompasses this life.  If you'd like to be the first to receive updates and exclusive content from the upcoming Breast Cancer Life newsletter, please email me at connect@breastcancerlife.org. I'd love to have you on the list! LET'S CONNECT: connect@breastcancerlife.org  Follow us on Pinterest 

I'm pulling back the curtain and sharing my own cancer surgery recovery playbook—my 5 rapid recovery tools that helped me bounce back faster than my doctor thought possible. You'll get the real story about my hysterectomy, the emotional rollercoaster of a cancer diagnosis (yep, I'm officially cancer-free!), and the exact science-backed strategies I used to speed heal, crush inflammation, support my immune system, and get back to the gym way ahead of schedule. If cancer, surgery, or just flat-out “I need to heal now” vibes are on your radar, this is the badass protocol you've been waiting for. Trust me, you don't want to miss this one. I break down my top tools—from black cumin seed oil (a total inflammation-buster and cancer-fighting powerhouse), to red light therapy, to grounding with the Aligned Mat, optimizing hormone health with my go-to supplement, and of course, strategic use of cutting-edge peptides. Whether you're facing a tough diagnosis or just want to bulletproof your body, these tactics aren't just for post-op—they're for life and prevention, too. Listen in to get the actionable steps, the “why” behind each one, and your first-class ticket to never hearing that C word. Prevention, healing, and next-level thriving—all inside this episode! Dr. Amie's Healing Protocol: https://health.dramie.com/healing-protocol WHAT DO MY LABS MEAN?! Try the ultimate tool to Decode Your Labs: Understand your thyroid, hormones, and blood sugar numbers to transform your health https://dramie.com/labs/ We prescribe to all 50 states!  When you're ready to FINALLY get the help you deserve… Book a free application call: https://dramie.com/book-a-call/ Shop ALL of Dr. Amie's Fixxr® Supplements: https://betterlifedoctor.com/ EARN CE Credits: "Nurses, hold-on  – here comes the exciting part: you can earn nursing CE credits by listening to our podcasts! That's right—RNegade has teamed up with podcast hosts like me who are delivering amazing content that doesn't limit you to “thinking outside-the box,” it challenges you to BLOW-UP the box by learning from innovators, pioneers, and RENEGADES in the field of health and medicine WHILE EARNING YOUR CEs!” https://rnegade.thinkific.com/?ref=4d98d0 RATE, REVIEW AND FOLLOW ON APPLE PODCASTS If you made it this far I'm impressed! That means you really love the show and I love you for that!  So I'm going to ask you for a favor. Would you please leave a quick review or even 5⭐️. I DO read them and can't tell you how much I appreciate it! Thank you in advance!❤️  Just click here it's quick and easy : https://podcasts.apple.com/us/podcast/the-thyroid-fixer/id1529800263,  Ok ONE MORE favor…would you please subscribe and follow the show? This is a win-win! It tells the podcast powers that be that you like The Thyroid Fixer Podcast AND it lets you catch all the new episodes that come out every week. Follow with this link: https://podcasts.apple.com/us/podcast/the-thyroid-fixer/id1529800263 and never miss out on a moment of the journey! CONNECT WITH ME ON SOCIAL MEDIA: Want to get your labs reviewed and your questions answered LIVE by me? Join my exclusive Facebook group, Just Fix Your Thyroid – a supportive and empowering community designed to give you the tools, guidance, and HOPE you need on your thyroid and hormone journey.

Melvin J. Silverstein, now Medical Director of Hoag Breast Center and the Gross Family Foundation Endowed Chair in Oncoplastic Breast Surgery at USC, sat down with Stacy Wentworth, radiation oncologist and medical historian, to reflect on his career.Silverstein founded the Van Nuys Breast Center in 1979. As he saw more and more and more patients with what was only recently coming to be known as ductal carcinoma in situ (DCIS), he wrote the first major textbook on the disease and developed the Van Nuys Classification for Ductal Carcinoma in Situ of the Breast as well as the USC Van Nuys Prognostic Index.Wentworth asked Silverstein about a time when his science was challenged by the medical establishment. At the time, most surgeons favored treating DCIS just like aggressive, invasive breast cancers, with mastectomy and radiation.Silverstein wasn't so sure about that. He felt that, in some cases, radiation wasn't necessary.Silverstein debated against radiation oncologists at conferences for years, and his arguments stirred up visceral responses, he recalls.“Pro-radiation therapy were all the radiation oncologists from academic centers. That was Jay Harris, who was I guess my arch rival in this. He once, after one of these talks, came up to me, smiled at me and said, ‘You're killing patients.' Which broke my heart,” Silverstein said. “It was a terrible thing. He said to me after not giving radiation therapy, but it turns out in the long run, everybody's come on board. And clearly now it's 25, 30 years later, some people have finally agreed that they all don't need it.”Recent trial results have confirmed Silverstein's analysis that not all patients with DCIS need radiation.Today, Silverstein runs the USC breast fellowship program, which has an emphasis on oncoplastic surgery—the first of its kind.Read more at https://cancerhistoryproject.com/article/melvin-silverstein/

Learn how your treatment plan is decided and terms you may seeWe continue our series to help you understand cancer and its treatment. This week we focus on surgery, the oldest form of cancer treatment. Learn about surgery timing, types of cancer surgery, and how NCCN evidence-based guidelines provide a standard treatment path no matter where you are.In this Episode:02:58 - Wisconsin-Cheese, UFOs, and Booyah Stew04:52 - Anna Quindlen: Get a Life Where You Are Generous"08:06 - Medical Specialists Involved in Cancer Care08:52 - Treatment Decisions, Tumor Board and NCCN Guidelines12:03 - Adjuvant and Neoadjuvant Therapy13:13 - Surgery Timing, Reasons and Types18:00 - Discussion - NCCN and Role of Research24:34 - Reeves Keyworth:“On Loved Ones Telling the Dying to ‘Let Go”23:54 - OutroSurgery, radiation therapy, and chemotherapy alone or in combination are the most-common methods used to treat cancer. Specific treatment varies depending on the kind of cancer, the extent of the disease, its rate of progression, and the condition of the person. Surgery alone may not result in a cure and often chemotherapy and/or radiation are needed after surgery. Learn all about surgery and the guidelines your doctor will be following for your treatment.Support the showGet show notes and resources at our website: every1dies.org. Facebook | Instagram | YouTube | mail@every1dies.org

Dr. Constanze Rayhrer, breast surgeon with Franciscan Health, discusses breast cancer surgery options such as lumpectomy and mastectomy, and explains why a patient might consider each.

Rev. Jodi of Self-Cell Care, Suson Essentials, welcomes Ryan Encinas, a holistic RN, specializes in metabolic health and mindset optimization. Utilizing Nobel Prize-winning Physics, the Bio Scanner, he teaches cellular antioxidant metrics to address nutrient deficiencies. Ryan collaborates with diverse health practitioners to promote prevention and measurable nutrient optimization. With a background in Cancer Surgery at MD Anderson, his experience spans surgical assistance, directorial roles, and Bio Chem, Cell Function, Genetics, and Spirituality. He emphasizes personalized nutrition, lifestyle modifications, and stress management with radical ownership to enhance health span. " We are a system, not symptoms."  All Dis-ease boil down to 2 things. 1. deficiency 2. toxicity Guest: Ryan Encinas, ryan@my-holistic-hub.com , https://holistichub.gethealthyusa.com..., * IG:   / _holistic_hub   FB:   / 18akl2uoom   in:   / ryan-encinas-holistihub   Host: Rev. Jodi Suson Jodi@SusonEssentials.com ; www.susonessentials.com, YouTube    / @susonessentials   Facebook   / susonessentials   Twitter   / susonessentials   Instagram    / susonessentials    

Listen to the final episode of this 4-part Women in Cancer Surgery podcast series on finance hosted through SurgOnc Today®. In this episode, Dr. Melissa Hogg, a member of the Women in Cancer Surgery Committee, and Dr. Tari King, Chief of Breast Surgery at Dana-Farber Brigham Cancer Center discuss organizational fund flow and share insights on managing financial matters in the field.

In this episode of SurgOnc Today®, Dr. Patricio Polanco, from the University of Texas Southwestern and Vice-chair of the SSO HPB disease site working group, and Dr. Sandra DiBrito, from Albany Medical College and member of the HPB disease site working group, are joined by Dr. Marc Besselink, of Amsterdam University Medical Center, and Dr. Amer Zureikat, of University of Pittsburgh. This is the second episode in our Minimally Invasive Techniques in Hepatobiliary Surgery Series. We will focus today on minimally invasive pancreas surgery.

In this episode of SurgOnc Today®, Dr. Patricio Polanco from the University of Texas Southwestern and Vice-chair of the SSO HPB disease site working group and Dr. Sandra DiBrito from Albany Medical College and member of the HPB disease site working group are joined by Dr. Asmund Fretland of the University of Oslo and Dr. Laleh Melstrom of City of Hope. This is the first episode in our Minimally Invasive Techniques in Hepatobiliary Surgery Series. We will focus on the minimally invasive surgery techniques on the liver, discussing patient selection, benefits of the MIS approach, potential drawbacks, and the impact of this approach on patient outcomes.

Listen to Part 3 of this 4-part Women in Cancer Surgery podcast series on finance hosted through SurgOnc Today®. In this episode, Women in Cancer Surgery Committee Members, Drs. Anita Mamtani and Erika Schmitz, are joined by Bryan Neel, Lead Staff Financial Planner for Physicians and Executives at the Mayo Clinic in Florida. Together, they'll discuss financial literacy as it relates to insurance, disability, retirement, and more.

Listen to Part 2 of this 4-part Women in Cancer Surgery podcast series on finance hosted through SurgOnc Today®. In this episode, Women in Cancer Surgery Committee Members, Drs. Maggie DiNome and Andrea Barrio, are joined by Karen Price, Senior Revenue Manager - Department of Surgery, at Duke University. They will focus on an in-depth discussion of coding strategies and tips to improve billing, understand the use of relevant modifiers, and the use of time-based billing.

Join us for Part 1 of this 4-part Women in Cancer Surgery podcast series on finance hosted through SurgOnc Today. In this episode, Chair of the Women in Cancer Surgery Committee, Dr. Sarah McLaughlin, and Committee Member, Dr. Aimee Crago, will be joined by Alice Rigdon, Chief Financial Officer at the Mayo Clinic in Florida to provide a primer on financial literacy as it relates to department, division, and institutional finances. It will provide a broad framework of common terms and associated financial definitions.

Imagine if a single blood test could tell clinicians in real time how successful a cancer surgery has been. A recent study from the University of Brasília, published in Oncotarget, suggests that such an approach might soon be possible. By tracking changes in cell-free DNA (cfDNA) levels before, during, and after colorectal cancer (CRC) surgery, researchers have found a potential new way to monitor tumor removal and predict patient outcomes. Cell-Free DNA and Colorectal Cancer Surgery Cell-free DNA consists of tiny fragments of genetic material that are released into the bloodstream when cells break down. In healthy individuals, these fragments come from normal cell turnover, but in cancer patients, some of this DNA originates from tumor cells. cfDNA detection has been used to track cancer progression and treatment response in diseases like lung, breast, and CRC. What had not been investigated until now was how cfDNA levels fluctuate during cancer surgery itself. Since surgery is the primary treatment for CRC, understanding how cfDNA levels change during surgical intervention could provide valuable insights into whether the tumor has been fully removed and how the patient's body reacts to the procedure. The Study: Measuring Cell-Free DNA in Real-Time In the study, titled “Assessment of cfDNA release dynamics during colorectal cancer surgery,” led by first author Mailson Alves Lopes and corresponding author Fabio Pittella-Silva, scientists analyzed ​​blood plasma samples from 30 CRC patients at three critical time points—before, during, and after surgery. Using highly sensitive genetic tests, they measured changes in cfDNA concentration to determine whether surgery had a direct impact on its release. The goal was to check whether cfDNA could serve as a biomarker for evaluating surgical effectiveness and predicting the probability of cancer recurrence. Full blog - https://www.oncotarget.org/2025/02/26/how-a-simple-blood-test-could-predict-colorectal-cancer-surgery-success/ Paper DOI - https://doi.org/10.18632/oncotarget.28681 Correspondence to - Fabio Pittella-Silva - pittella@unb.br Video short - https://www.youtube.com/watch?v=jC5_xqIrbtA Sign up for free Altmetric alerts about this article - https://oncotarget.altmetric.com/details/email_updates?id=10.18632%2Foncotarget.28681 Subscribe for free publication alerts from Oncotarget - https://www.oncotarget.com/subscribe/ Keywords - cancer, colorectal cancer, cfDNA, surgery About Oncotarget Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science. Oncotarget is indexed and archived by PubMed/Medline, PubMed Central, Scopus, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science). To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: Facebook - https://www.facebook.com/Oncotarget/ X - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh MEDIA@IMPACTJOURNALS.COM

BUFFALO, NY - January 27, 2025 – A new #research paper was #published in Oncotarget's Volume 16 on January 21, 2025, titled “Assessment of cfDNA release dynamics during colorectal cancer surgery." Researchers from the University of Brasília investigated how cell-free DNA (cfDNA) levels in the blood change before, during, and after colorectal cancer surgery. The study found that cfDNA levels increase significantly during and after surgery. The findings suggest that cfDNA could help clinicians evaluate surgery effectiveness and monitor patient outcomes. cfDNA consists of small DNA fragments released into the bloodstream when cells die and break apart. In healthy individuals, cfDNA usually comes from normal cell turnover, while in cancer patients, some of it originates from tumor cells. Measuring cfDNA levels offers valuable insights into a patient's condition and is already being used to track disease progression and treatment response in cancers such as lung, breast, and colorectal cancer. Colorectal cancer is one of the most common cancers worldwide, affecting millions of people each year. Surgery is often the primary treatment, but up to 50% of patients experience cancer recurrence afterward. In this study, the research team, led by first author Mailson Alves Lopes and corresponding author Fabio Pittella-Silva, analyzed blood samples from 30 patients at three key time points: before, during, and after surgery. It was found that cfDNA levels increased nearly threefold during surgery and doubled after surgery compared to pre-surgery levels. The increases were even higher in individuals over 60, those with preexisting conditions such as diabetes or heart disease, and patients with elevated levels of carcinoembryonic antigen (CEA), a common cancer marker. Patients with the highest cfDNA levels were those with larger or more aggressive tumors, likely due to greater tissue damage during surgery. Additionally, longer surgeries were linked to higher cfDNA levels. “[...]we observed that cfDNA concentration may rise in correlation with the duration of the surgery, highlighting its potential as a marker of surgical quality.” These findings suggest that cfDNA could be a valuable, non-invasive biomarker for clinicians to monitor colorectal cancer patients. Tracking cfDNA levels may help better evaluate surgical outcomes and determine whether patients require closer follow-up care. While these findings are promising, further research is needed to standardize cfDNA testing and validate its usefulness. Larger studies could help establish cfDNA testing as a reliable tool for cancer care and postoperative monitoring, with the potential to become a routine part of clinical practice in the future. DOI - https://doi.org/10.18632/oncotarget.28681 Correspondence to - Fabio Pittella-Silva - pittella@unb.br Video short - https://www.youtube.com/watch?v=jC5_xqIrbtA About Oncotarget Oncotarget (a primarily oncology-focused, peer-reviewed, open access journal) aims to maximize research impact through insightful peer-review; eliminate borders between specialties by linking different fields of oncology, cancer research and biomedical sciences; and foster application of basic and clinical science. Oncotarget is indexed and archived by PubMed/Medline, PubMed Central, Scopus, EMBASE, META (Chan Zuckerberg Initiative) (2018-2022), and Dimensions (Digital Science). To learn more about Oncotarget, please visit https://www.oncotarget.com and connect with us: Facebook - https://www.facebook.com/Oncotarget/ X - https://twitter.com/oncotarget Instagram - https://www.instagram.com/oncotargetjrnl/ YouTube - https://www.youtube.com/@OncotargetJournal LinkedIn - https://www.linkedin.com/company/oncotarget Pinterest - https://www.pinterest.com/oncotarget/ Reddit - https://www.reddit.com/user/Oncotarget/ Spotify - https://open.spotify.com/show/0gRwT6BqYWJzxzmjPJwtVh MEDIA@IMPACTJOURNALS.COM

Dr. Brooke Britton, veterinary oncologist, answers a listener's question about their dog's large mammary tumor and whether waiting a week for surgery is too long. Dr. Britton discusses the complexities of surgery for large tumors, alternative treatment options, and ways to manage your dog's comfort while waiting for surgery. Episode Highlights Listener question from Gio about a ruptured mammary tumor in his dog. Expert advice on surgical timing and tumor management. Practical tips for improving your dog's quality of life while awaiting treatment. Key Takeaways A week may be a reasonable timeframe for surgery if the tumor appears stable. Some tumors deemed "too large" may still be partially removed to improve quality of life. Consult a veterinary surgeon for advanced cases and second opinions. Manage your dog's comfort with appropriate medications, coverings, and e-collars. Your Voice Matters! If you have a question for our team, or if you want to share your own hopeful dog cancer story, we want to hear from you! Go to https://www.dogcancer.com/ask to submit your question or story, or call our Listener Line at +1 808-868-3200 to leave a question. Related Videos: https://www.youtube.com/watch?v=7n8I67ejtRo Related Links: A comprehensive guide to surgery for your dog: https://www.dogcancer.com/articles/diagnosis-and-medical-procedures/your-dog-surgery-guide/ An overview of breast cancer in dogs: https://www.dogcancer.com/articles/types-of-dog-cancer/mammary-tumors-in-dogs/ Chapters: 00:00 Introduction 00:15 Listener Call: Gio's Question 02:00 Is a Week Too Long to Wait? 03:30 What If the Tumor Is "Too Large"? 05:15 Specialist vs. General Practitioner Vets 09:00 Managing Your Dog's Comfort 13:15 Why Surgery Is Usually the Best Option 14:00 Closing Thoughts   Get to know Dr. Brooke Britton: https://www.dogcancer.com/people/brooke-britton-dvm-dacvim-oncology/ For more details, articles, podcast episodes, and quality education, go to the episode page: https://www.dogcancer.com/podcast/ Learn more about your ad choices. Visit megaphone.fm/adchoices

'Out of Control': Insurance Giant UnitedHealth Calls in Middle of Cancer Surgery to Question Necessity. FINALLY- The myth of a failed Jimmy Carter presidency was imploded with this eulogy. Subscribe to our Newsletter: https://politicsdoneright.com/newsletter Purchase our Books: As I See It: https://amzn.to/3XpvW5o How To Make America Utopia: https://amzn.to/3VKVFnG It's Worth It: https://amzn.to/3VFByXP Lose Weight And Be Fit Now: https://amzn.to/3xiQK3K Tribulations of an Afro-Latino Caribbean man: https://amzn.to/4c09rbE

Jase refuses to believe in the merits of pedicures, even though Al sings their praises, and Lisa returns for an update on her second reconstructive surgery post-breast cancer. Jase compares the fake news of man-made gods to the good news of the gospel, and Jesus was the prototype for God becoming man as well as God living among men. Lisa relates her tale of desperation that led her to Christ and how she realized she'd made her husband the lord of her life instead of Jesus.  In this episode: Colossians 1; Colossians 2; 1 Corinthians 8, verses 1-6 “Unashamed” episode 979 is sponsored by: https://preborn.com/unashamed — SAVE babies with your tax-deductible donation today! https://alpinegold.com — Get FREE shipping on orders over $200 with code UNASHAMED. https://BlazeUnlimited.com/Unashamed — Claim your spot & join the mission to defend free speech & uphold the American way of life! https://philmerch.com — Get your “Unashamed” mugs, shirts, hats & hoodies! -- Learn more about your ad choices. Visit megaphone.fm/adchoices

Kennedy is back! Find out all the details about how she is feeling after having "Melvin" removed and what's next on her cancer journey. We also play Can't Beat Kennedy and 8 Bit Hits to give away some Post Malone tickets!

Kennedy is back  after having surgery to remove "Melvin" last Thursday. Find out how she is doing and what's next on her journey back to health.

Kennedy is back  after having surgery to remove "Melvin" last Thursday. Find out how she is doing and what's next on her journey back to health.

Welcome back to our weekend Cabral HouseCall shows! This is where we answer our community's wellness, weight loss, and anti-aging questions to help people get back on track! Check out today's questions:    Vikki: My son had kawasaki disease at 5yo. In hospital for week, got 2 IVIG treatments & high doses aspirin. Heart always looked good. Hes 16 & has been dealing w mild hearing loss& tinnitus, what can he do to lessen ringing or reverse? Assuming it was caused by the disease. Covid made it worse (no shot). Dizzy when it's at its worst. Avoids loud places, like movie theatre/church. Tried hearing aids but says didn't help. Healthy otherwise. Also what do you know about Kawasaki& future complications? TY   Fiona: I have used your products to correct my autoimmune issues, thank you so much for helping me. My daughter is fighting a EBV infection and is so exhausted every day. She has just had an IV vitamin C treatment. She also has Enterococus Avium detected in stool. Bifidobacterium bifidium and breve, Lactobacillus plantarum, casei and acidophlis have low readings. What is the best protocol for her to follow please   Jay: Hi Dr. Cabral I want to thank you and your team for all the work you do - it has been life changing for both me and my clients. I ran the big 5 did FM 21 detox, HMD, Ultimate sleep, Estrogen detox, and in the CBO protocol. I am wondering if you could tell me when I could retest to see improvement (looking to concieve - want to make sure everything is optimized). For reference I had low DHEA, high cortisol, estrogen dominance, + mercury, + aluminum candida, and oxalic acid.   Patricia: Dear Dr. Cabral, thank you for all the information and knowledge you share, it has really made a difference in my life. This question is related to my father, he is 84 years old and recently diagnosed with skin cancer on different areas on his face,we believe it was caused to sun exposure and or chemicals due to his job when younger as a Petroleum Engineer working in the field. He has molds in his face and his back, some of those cancerous. One was recently removed from his tear duct cancerous. He is scheduled to have surgery soon for all the others found. Is there any recommendation you can give me on things that he can do before and after the procedure related to diet and supplements that can help him heal faster and prevent recurrencies? I value so much your opinion. Thank you so much   Fernanda: I bought an EquiLife heavy metal detox kit for me and my husband and I just did your regular detox course online. Now I am wondering how these 2 compare. We don't want to lose weight as we are overall healthy already. We have completed three 5-day fasts using another product (Prolon) recently. How does a 5-day fast compare to EquiLife 7 day detox as far as removing toxins go? Will the removal of toxins in a 5-day water only or Prolon fast be compromised because there may not be enough amino acids to aid the phase 2 detox pathways? Should I do the regular detox before the heavy metal one? Please feel free to email me directly if that is not a question that you would like to answer on the podcast. FYI: I am also currently an IHP1 student and I bought 8 of the books you recommended so far.   Thank you for tuning into today's Cabral HouseCall and be sure to check back tomorrow where we answer more of our community's questions!    - - - Show Notes and Resources: StephenCabral.com/3032 - - - Get a FREE Copy of Dr. Cabral's Book: The Rain Barrel Effect - - - Join the Community & Get Your Questions Answered: CabralSupportGroup.com - - - Dr. Cabral's Most Popular At-Home Lab Tests: > Complete Minerals & Metals Test (Test for mineral imbalances & heavy metal toxicity) - - - > Complete Candida, Metabolic & Vitamins Test (Test for 75 biomarkers including yeast & bacterial gut overgrowth, as well as vitamin levels) - - - > Complete Stress, Mood & Metabolism Test (Discover your complete thyroid, adrenal, hormone, vitamin D & insulin levels) - - - > Complete Food Sensitivity Test (Find out your hidden food sensitivities) - - - > Complete Omega-3 & Inflammation Test (Discover your levels of inflammation related to your omega-6 to omega-3 levels) - - - Get Your Question Answered On An Upcoming HouseCall: StephenCabral.com/askcabral - - - Would You Take 30 Seconds To Rate & Review The Cabral Concept? The best way to help me spread our mission of true natural health is to pass on the good word, and I read and appreciate every review!